View in EDS HTML Full Text PDF Full Text

High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China.

Saved in:
Bibliographic Details
Title: High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China.
Authors: Jia HH; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.; School of Preclinical Medicine, Guangxi Medical University, Nanning, China., Li KW; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China., Chen QY; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China., Wang XY; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China., Harrison TJ; Division of Medicine, UCL Medical School, London, United Kingdom., Liang SJ; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China., Yang QL; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China., Wang C; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China., Hu LP; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China., Ren CC; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.; School of Preclinical Medicine, Guangxi Medical University, Nanning, China., Fang ZL; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, Chinazhongliaofang@hotmail.com.
Source: Intervirology [Intervirology] 2018; Vol. 61 (3), pp. 123-132. Date of Electronic Publication: 2018 Oct 26.
Publication Type: Journal Article
Journal Info: Publisher: Karger Country of Publication: Switzerland NLM ID: 0364265 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1423-0100 (Electronic) Linking ISSN: 03005526 NLM ISO Abbreviation: Intervirology Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
FullText Links:
  – Type: pdflink
Text:
  Availability: 1
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 30368502
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Jia+HH%22">Jia HH</searchLink>; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.; School of Preclinical Medicine, Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Li+KW%22">Li KW</searchLink>; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Chen+QY%22">Chen QY</searchLink>; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Wang+XY%22">Wang XY</searchLink>; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Harrison+TJ%22">Harrison TJ</searchLink>; Division of Medicine, UCL Medical School, London, United Kingdom.<br /><searchLink fieldCode="AU" term="%22Liang+SJ%22">Liang SJ</searchLink>; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Yang+QL%22">Yang QL</searchLink>; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Wang+C%22">Wang C</searchLink>; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Hu+LP%22">Hu LP</searchLink>; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Ren+CC%22">Ren CC</searchLink>; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, China.; School of Preclinical Medicine, Guangxi Medical University, Nanning, China.<br /><searchLink fieldCode="AU" term="%22Fang+ZL%22">Fang ZL</searchLink>; Guangxi Zhuang Autonomous Region Center for Disease Prevention and Control, Guangxi Key Laboratory for the Prevention and Control of Viral Hepatitis, Nanning, Chinazhongliaofang@hotmail.com.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%220364265%22">Intervirology</searchLink> [Intervirology] 2018; Vol. 61 (3), pp. 123-132. <i>Date of Electronic Publication: </i>2018 Oct 26.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Karger%22">Karger </searchLink><i>Country of Publication: </i>Switzerland <i>NLM ID: </i>0364265 <i>Publication Model: </i>Print-Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>1423-0100 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2203005526%22">03005526 </searchLink><i>NLM ISO Abbreviation: </i>Intervirology <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=30368502
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1159/000493797
    Languages:
      – Code: eng
        Text: English
    PhysicalDescription:
      Pagination:
        StartPage: 123
    Titles:
      – TitleFull: High Prevalence of HBV Lamivudine-Resistant Mutations in HBV/HIV Co-Infected Patients on Antiretroviral Therapy in the Area with the Highest Prevalence of HIV/HBV Co-Infection in China.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Jia HH
      – PersonEntity:
          Name:
            NameFull: Li KW
      – PersonEntity:
          Name:
            NameFull: Chen QY
      – PersonEntity:
          Name:
            NameFull: Wang XY
      – PersonEntity:
          Name:
            NameFull: Harrison TJ
      – PersonEntity:
          Name:
            NameFull: Liang SJ
      – PersonEntity:
          Name:
            NameFull: Yang QL
      – PersonEntity:
          Name:
            NameFull: Wang C
      – PersonEntity:
          Name:
            NameFull: Hu LP
      – PersonEntity:
          Name:
            NameFull: Ren CC
      – PersonEntity:
          Name:
            NameFull: Fang ZL
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 01
              M: 01
              Text: 2018
              Type: published
              Y: 2018
          Identifiers:
            – Type: issn-electronic
              Value: 1423-0100
          Numbering:
            – Type: volume
              Value: 61
            – Type: issue
              Value: 3
          Titles:
            – TitleFull: Intervirology
              Type: main
ResultId 1